Injectable versus oral naltrexone treatment of alcohol dependence in serious mental illness (SMI): a pilot study

Trial Profile

Injectable versus oral naltrexone treatment of alcohol dependence in serious mental illness (SMI): a pilot study

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Naltrexone (Primary) ; Naltrexone
  • Indications Alcohol withdrawal; Bipolar disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Mar 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
    • 08 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top